The Enterprise Value as of December 2024 (TTM) for CollPlant Biotechnologies Ltd. (CLGN) is 27.97M

According to CollPlant Biotechnologies Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.97M. This represents a change of -36.34% compared to the average of 43.94M of the last 4 quarters.

CollPlant Biotechnologies Ltd. (CLGN) Historical Enterprise Value (quarterly & annually)

How has CLGN Enterprise Value performed in the past?

The mean historical Enterprise Value of CollPlant Biotechnologies Ltd. over the last ten years is 44.89M. The current 27.97M Enterprise Value has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), CLGN's Enterprise Value was at its highest in in the June 2021 quarter at 202.18M. The Enterprise Value was at its lowest in in the March 2015 quarter at 7.45M.

CollPlant Biotechnologies Ltd. (CLGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CollPlant Biotechnologies Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CollPlant Biotechnologies Ltd. (CLGN) Average Enterprise Value

How has CLGN Enterprise Value performed in the past?

The current Enterprise Value of CollPlant Biotechnologies Ltd. (CLGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CollPlant Biotechnologies Ltd. (CLGN) Enterprise Value vs. Peers

How is CLGN’s Enterprise Value compared to its peers?

CollPlant Biotechnologies Ltd.’s Enterprise Value is less than Keros Therapeutics, Inc. (165.48M), less than Merus N.V. (2.47B), less than Vericel Corporation (2.87B), less than Century Therapeutics, Inc. (89.16M), greater than Shattuck Labs, Inc. (12.78M), less than C4 Therapeutics, Inc. (280.63M), less than Eliem Therapeutics, Inc. (0), less than Prelude Therapeutics Incorporated (71.12M), less than Monte Rosa Therapeutics, Inc. (351.25M), less than Molecular Partners AG (107.67M), less than MediciNova, Inc. (59.45M), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than Champions Oncology, Inc. (112.78M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Replimune Group, Inc. (904.39M), less than Crinetics Pharmaceuticals, Inc. (4.74B), less than NewAmsterdam Pharma Company N.V. (2.35B), less than PureTech Health plc (313.18M), less than Ikena Oncology, Inc. (37.04M), less than Enochian Biosciences, Inc. (167.08M), greater than HCW Biologics Inc. (26.86M), less than Exicure, Inc. (50.55M),

Build a custom stock screener for CollPlant Biotechnologies Ltd. (CLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CollPlant Biotechnologies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CollPlant Biotechnologies Ltd. (CLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CollPlant Biotechnologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.